Falling
outside of Lipinski’s rule of five, macrocyclic
drugs have accessed unique binding sites of their target receptors
unreachable by traditional small molecules. Cyclosporin(e) A (CycA),
an extensively studied macrocyclic natural product, is an immunosuppressant
with undesirable side effects such as electrolytic imbalances. In
this work, a comprehensive view on the conformational landscape of
CycA, its interactions with Ca2+, and host–guest
interactions with cyclophilin A (CypA) is reported through exhaustive
analyses that combine ion-mobility spectrometry–mass spectrometry
(IMS–MS), nuclear magnetic resonance (NMR) spectroscopy, distance-geometry
modeling, and NMR-driven molecular dynamics. Our IMS–MS data
show that CycA can adopt extremely compact conformations with significantly
smaller collisional cross sections than the closed conformation observed
in CDCl3. To adopt these conformations, the macrocyclic
ring has to twist and bend via cis–trans isomerization of backbone amides, and thus, we termed
this family of structures the “bent” conformation. Furthermore,
NMR measurements indicate that the closed conformation exists at 19%
in CD3OD/H2O and 55% in CD3CN. However,
upon interacting with Ca2+, in addition to the bent and
previously reported closed conformations of free CycA, the CycA:Ca2+ complex is open and has all-trans peptide
bonds. Previous NMR studies using calcium perchlorate reported only
the closed conformation of CycA (which contains one cis peptide bond). Here, calcium chloride, a more biologically relevant
salt, was used, and interestingly, it helps converting the
cis
-MeLeu9–MeLeu10 peptide bond
into a trans bond. Last, we were able to capture
the native binding of CycA and CypA to give forth evidence that IMS–MS
is able to probe the solution-phase structures of the complexes and
that the Ca2+:CycA complex may play an essential role in
the binding of CycA to CypA.